Beijing, China

Yuchuan Wu

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 3.3

ph-index = 1


Location History:

  • Beijing, CN (2021 - 2022)
  • Suzhou, CN (2023)

Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):

Title: Yuchuan Wu: Innovator in Pharmaceutical Chemistry

Introduction

Yuchuan Wu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of six patents to his name, Wu's work is recognized for its innovative approaches to treating diseases.

Latest Patents

Among his latest patents is a novel EZH2 inhibitor compound, which is represented by a specific formula. This invention provides a method for preventing or treating diseases mediated by EZH2. Another notable patent involves a heterocyclic compound, which includes its application and a pharmaceutical composition comprising the same. This compound has a unique structure and demonstrates strong inhibitory activity against autotaxin (ATX).

Career Highlights

Yuchuan Wu has worked with several reputable companies in the pharmaceutical industry. Notably, he has been associated with Suzhou Sinovent Pharmaceuticals Co., Ltd. and Evopoint Biosciences Co., Ltd. His work in these organizations has contributed to advancements in drug development and therapeutic solutions.

Collaborations

Throughout his career, Wu has collaborated with esteemed colleagues, including Yonghan Hu and Xi Chen. These partnerships have fostered a collaborative environment that enhances innovation and research in pharmaceutical sciences.

Conclusion

Yuchuan Wu's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His innovative compounds have the potential to make significant impacts in the treatment of various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…